Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations and Comprehensive Loss

v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 97,203 $ 55,424
General and administrative 27,938 19,236
Total operating expenses 125,141 74,660
Loss from operations (125,141) (74,660)
Other income:    
Interest income 10,025 6,985
Interest expense (748) 0
Net loss (115,864) (67,675)
Other comprehensive income:    
Net unrealized (loss) gain on available-for-sale investments, net of tax (39) 86
Net comprehensive loss $ (115,903) $ (67,589)
Net loss per share of voting and non-voting common stock, basic $ (2.34) $ (1.65)
Net loss per share of voting and non-voting common stock, diluted $ (2.34) $ (1.65)